Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and DurvalumabSilvia Camera, Giovanni Farinea, Mario Domenico Rizzato et al.|Targeted Oncology|2026Cited by 1
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patientsMaria Lucia Iacovino, Francesco Perrone, Laura Arenare et al.|Lung Cancer|2026Cited by 0